Inventor · disambiguated record
Carl P. Decicco
Also filed as: DECICCO CARL · DECICCO CARL P · DECICCO CARL PETER
36 granted patents·3 pending applications·712 citations·filing 1996–2021
98Inventor score
Files withBRISTOL MYERS SQUIBB CO14BRISTOL MYERS SQUIBB PHARMA CO13DU PONT PHARM CO3DU PONT MERCK PHARMA2CORTE JAMES R1
Top patents by PatentIndex Score
39 records- 0197US6403632B1Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jun 11, 2002·78 cites·18 claims
- 0294US6858626B2Cyclic hydroxamic acid as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 22, 2005·66 cites·20 claims
- 0394US6803374B2Compounds useful for treating hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 12, 2004·41 cites·15 claims
- 0492US8828983B2Macrocycles as factor XIa inhibitorsQUAN MIMI L·Filed 2011·Granted Sep 9, 2014·13 cites·14 claims
- 0591US10487086B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·3 cites·9 claims
- 0691US8940720B2Macrocycles as factor XIa inhibitorsCORTE JAMES R·Filed 2011·Granted Jan 27, 2015·6 cites·4 claims
- 0791US6495565B2β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 17, 2002·50 cites·70 claims
- 0891US6429213B1Cyclic hydroxamic acids as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Aug 6, 2002·95 cites·42 claims
- 0989US9802939B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 31, 2017·3 cites·9 claims
- 1089US7122627B2Lactam inhibitors of Hepatitis C virus NS3 proteaseBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Oct 17, 2006·35 cites·25 claims
- 1186US11136327B2Macrocycles as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·1 cites·11 claims
- 1286US9453029B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·2 cites·13 claims
- 1386US6376665B1Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseDU PONT PHARM CO·Filed 2000·Granted Apr 23, 2002·23 cites·23 claims
- 1486US6268379B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsDU PONT PHARM CO·Filed 1999·Granted Jul 31, 2001·71 cites·28 claims
- 1585US9079918B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 14, 2015·2 cites·12 claims
- 1682US6984648B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 10, 2006·15 cites·21 claims
- 1782US6743807B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 1, 2004·15 cites·42 claims
- 1881US6689771B2Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanaseBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Feb 10, 2004·14 cites·30 claims
- 1981US5703092AHydroxamic acid compounds as metalloprotease and TNF inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Dec 30, 1997·58 cites·11 claims
- 2080US12404274B2Macrocycles as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 2179US6610731B2Lactam metalloprotease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 26, 2003·8 cites·17 claims
- 2277US7049412B1Antibodies to aggrecan-degrading metalloprotease and diagnostic methods using sameBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 23, 2006·3 cites·3 claims
- 2376US7557137B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 7, 2009·9 cites·7 claims
- 2473US6521436B1Nucleic acids encoding aggrecan degrading metallo proteasesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 18, 2003·6 cites·4 claims
- 2571US6989139B2Matrix metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 24, 2006·5 cites·24 claims
- 2671US6642255B21,2,-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alphaBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 4, 2003·5 cites·30 claims
- 2769US6451575B1Aggrecan degrading metallo proteasesBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Sep 17, 2002·20 cites·20 claims
- 2866US6576664B1Inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritisBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Jun 10, 2003·10 cites·36 claims
- 2965US9745313B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 29, 2017·0 cites·10 claims
- 3064US6884806B2Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 26, 2005·2 cites·18 claims
- 3164US6057336ALactam metalloprotease inhibitorsDU PONT·Filed 1998·Granted May 2, 2000·22 cites·54 claims
- 3262US6753176B2Aggrecan degrading metallo proteasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 22, 2004·2 cites·4 claims
- 3353US6365587B1Substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 1999·Granted Apr 2, 2002·9 cites·20 claims
- 3450US6281352B1Macrocyclic compounds as metalloprotease inhibitorsDU PONT PHARM CO·Filed 1997·Granted Aug 28, 2001·10 cites·50 claims
- 3548US2003073682A1Novel substituted aryl hydroxamic acids as metalloproteinase inhibitorsFiled 2002·Application pending·0 cites
- 3647US5691381AHydroxamic and carbocyclic acids as metalloprotease inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Nov 25, 1997·7 cites·4 claims
- 3747US2003134853A1Compounds useful for treating hepatitis C virusFiled 2002·Application pending·0 cites
- 3841US2004072802A1Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alphaFiled 2002·Application pending·0 cites
- 3939US6455522B1Cyclic sulfonamide derivatives as metalloproteinase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Sep 24, 2002·3 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Carl P. Decicco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →